- This event has passed.
ESE Fall Colloquium – “Micro- and Nanoscale Electro-fluidics: From Basic Research to Translational Medicine”
November 17, 2022 at 12:30 PM - 1:30 PM
In this talk, I will discuss my group’s work on fabricating micro- and nanosensing platforms for health monitoring. My group has developed novel electronic sensing modalities and has demonstrated their use for both in vitro with human clinical samples and in vivo in animals. In the first part of my talk, I will discuss sensor fabrication, characterization, and benchmarking against the gold standard, along with the role that these sensors can play in monitoring various chronic and acute inflammatory conditions. I will also discuss a new class of wirelessly powered nanobiosensors for immune monitoring. Finally, I will discuss challenges in translation of biosensing and microfluidic technologies beyond the lab, my personal experience, and potential solutions.
Mehdi Javanmard
Associate Professor in Electrical and Computer Engineering at Rutgers University
Mehdi Javanmard is an Associate Professor in the Electrical and Computer Engineering Department at Rutgers University. He received the BS (2002) from Georgia Institute of Technology and the MS (2004) and PhD (2008) all in electrical engineering from Stanford University. During his time at Stanford, he worked on the development of electronic microfluidic platforms for low-cost genomic and proteomic biomarker detection, and later worked as a Senior Research Engineer at the Stanford Genome Technology Center. In Fall 2014, he joined the Electrical and Computer Engineering Department, Rutgers University as an Assistant Professor. His research interests include developing portable and wearable technologies for continuous health monitoring and understanding the effects of the environment on health. In 2017, he was recipient of the Translational Medicine and Therapeutics Award by the American Society for Clinical Pharmacology and Therapeutics for his group’s work in point of care diagnostic tools for assessing patient response to cancer therapies. He has received various awards as a Principal Investigator from the National Science Foundation, National Institutes of Health, DARPA, and the PhRMA foundation to support his research. He was awarded the National Science Foundation CAREER Award for young faculty in 2019 and the DARPA Young Faculty Award in 2020. In 2018, he co-founded RizLab Health, a startup company dedicated to enabling point-of-care hematology analysis.